REG - BioPharma Credit PLC - Replacement: Dividend Declaration

Biopharma CreditAnnouncement

07/08/2019 13:00

For best results when printing this announcement, please click on link below:
http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20190802:nRSB2749Ia

RNS Number : 2749I
BioPharma Credit PLC
07 August 2019
 
The announcement released on 2 August 2019 at 4.00pm under reference 7938H
included an incorrect record date and currency election date in relation to
the interim dividend to be paid on 20 September 2019.
The correct record date and currency election date is 16 August 2019.
The corrected announcement is set out below.
 
BIOPHARMA CREDIT PLC
("BIOPHARMA CREDIT" OR THE "COMPANY")
DIVIDEND DECLARATION
BioPharma Credit PLC (LSE: BPCR), the specialist life sciences debt investor,
is pleased to declare an interim dividend in respect of the financial period
ending 30 June 2019 of $0.0175 per ordinary share, payable on 20 September
2019 to ordinary shareholders on the register as at 16 August 2019. The
Company has chosen to designate the entire amount of this interim dividend as
an interest distribution. Shareholders in receipt of such a dividend will be
treated for UK tax purposes as though they have received a payment of
interest. This will result in a reduction in the corporation tax payable by
the Company.
The Company is currently paying and continues to target a 7 cent annual
dividend per ordinary share.
The default payment for dividends is in US dollars. However, shareholders can
elect to have dividends paid in sterling (GBP) and the option to elect a
sterling dividend payment for this dividend will be available to shareholders
until 16 August 2019 (the "Election Date").
Further details together with a copy of the Dividend Currency Election Form,
which should be sent to Link Asset Services, The Registry, 34 Beckenham Road,
Beckenham, Kent, BR3 4TU when completed, will be available on the Group's
website shortly at www.bpcruk.com/investor-materials. CREST shareholders must
elect via CREST.
 
LEI: 213800AV55PYXAS7SY24
-Ends-
Link Company Matters Limited
Company Secretary
 
7 August 2019
 
Enquiries:
Buchanan
David Rydell / Mark Court / Jamie Hooper / Henry Wilson
+44 (0)20 7466 5000
Biopharmacredit@buchanan.uk.com
 
Notes to Editors:
BioPharma Credit PLC is London's only listed specialist investor in debt from
the life sciences industry and joined the LSE on 27 March 2017. The Company
seeks to provide long-term shareholder returns, principally in the form of
sustainable income distributions from exposure to the life sciences industry.
The Company seeks to achieve this objective primarily through investments in
debt assets secured by royalties or other cash flows derived from the sales of
approved life sciences products.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.